Exercise during chemotherapy: Friend or foe?
Sign Up to like & getrecommendations! Published in 2023 at "Cancer Medicine"
DOI: 10.1002/cam4.5831
Abstract: A higher chemotherapy completion rate is associated with better outcomes including treatment efficacy and overall survival. Exercise may have the potential to improve relative dose intensity (RDI) by reducing the frequency and severity of chemotherapy‐related… read more here.
Keywords: medicine; exercise chemotherapy; friend foe; exercise ... See more keywords
Wearable cardioverter‐defibrillator: friend or foe in suspected myocarditis?
Sign Up to like & getrecommendations! Published in 2021 at "ESC Heart Failure"
DOI: 10.1002/ehf2.13340
Abstract: Wearable cardioverter defibrillator (WCD, LifeVest, and Zoll) therapy has become a useful tool to bridge a temporarily increased risk for sudden cardiac death. However, despite extensive use, there is a lack of evidence whether patients… read more here.
Keywords: friend foe; wearable cardioverter; cardioverter defibrillator; defibrillator friend ... See more keywords
Friend or foe, the role of EGR-1 in cancer
Sign Up to like & getrecommendations! Published in 2019 at "Medical Oncology"
DOI: 10.1007/s12032-019-1333-6
Abstract: Early growth response-1 (EGR-1), also termed NEFI-A and Krox-24, as a multi-domain protein is implicated in several vital physiological processes, including development, metabolism, cell growth and proliferation. Previous studies have implied that EGR-1 was producing… read more here.
Keywords: role egr; egr cancer; egr; cancer ... See more keywords
Brain Exosomes: Friend or Foe in Alzheimer's Disease?
Sign Up to like & getrecommendations! Published in 2021 at "Molecular neurobiology"
DOI: 10.1007/s12035-021-02547-y
Abstract: Alzheimer's disease (AD) is the most common neurodegenerative disease. It is known to be a multifactorial disease and several causes are associated with its occurrence as well as progression. However, the accumulation of amyloid beta… read more here.
Keywords: brain exosomes; alzheimer disease; disease; physiology ... See more keywords
Targeting friend and foe: Emerging therapeutics in the age of gut microbiome and disease
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Microbiology"
DOI: 10.1007/s12275-018-8037-z
Abstract: Mucosal surfaces that line our gastrointestinal tract are continuously exposed to trillions of bacteria that form a symbiotic relationship and impact host health and disease. It is only beginning to be understood that the cross-talk… read more here.
Keywords: targeting friend; foe emerging; disease; therapeutics age ... See more keywords
Measurement uncertainty: Friend or foe?
Sign Up to like & getrecommendations! Published in 2018 at "Clinical biochemistry"
DOI: 10.1016/j.clinbiochem.2018.01.025
Abstract: The definition and enforcement of a reference measurement system, based on the implementation of metrological traceability of patients' results to higher order reference methods and materials, together with a clinically acceptable level of measurement uncertainty,… read more here.
Keywords: biochemistry; traceability; uncertainty; uncertainty friend ... See more keywords
Popular culture and genetics; friend, foe or something more complex?
Sign Up to like & getrecommendations! Published in 2019 at "European Journal of Medical Genetics"
DOI: 10.1016/j.ejmg.2018.12.005
Abstract: While many people enjoy popular culture, these transactional experiences may not translate into formal or academic learning about a subject. In education and science communication settings popular culture is often presented as a source of… read more here.
Keywords: culture genetics; genetics friend; genetics; popular culture ... See more keywords
Friend or foe: The divergent effects of FinTech on financial stability
Sign Up to like & getrecommendations! Published in 2020 at "Emerging Markets Review"
DOI: 10.1016/j.ememar.2020.100727
Abstract: Abstract Whether FinTech causes the fragility of financial institutions is a controversial issue. Using a panel sample of listed banks from 84 countries, we exploit the introduction of FinTech regulatory sandboxes as an exogenous shock… read more here.
Keywords: effects fintech; divergent effects; fragility financial; financial institutions ... See more keywords
Glycated proteins in nutrition: Friend or foe?
Sign Up to like & getrecommendations! Published in 2019 at "Experimental Gerontology"
DOI: 10.1016/j.exger.2018.11.012
Abstract: Advanced glycation end products (AGEs) are formed in in vivo, and accumulate in tissues and body fluids during ageing. Endogenous AGE-modified proteins show altered structure and function, and may interact with receptor for AGEs (RAGE)… read more here.
Keywords: proteins nutrition; glycated proteins; dietary ages; health ... See more keywords
The VDD ICD lead: Friend or Foe?
Sign Up to like & getrecommendations! Published in 2020 at "Indian Pacing and Electrophysiology Journal"
DOI: 10.1016/j.ipej.2020.04.008
Abstract: No abstract available Keywords: Atrial fibrillation; Atrial sensing; Defibrillator lead; Implantable cardioverter-defibrillator. read more here.
Keywords: lead friend; vdd icd; icd lead; lead ... See more keywords
Some comments on “Friend or Foe? Large canid remains from Pavlovian sites and their archaeozoological context”, a paper by Wilczyński et al. (2020)
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Anthropological Archaeology"
DOI: 10.1016/j.jaa.2021.101329
Abstract: Abstract Two canid morphotypes have been proposed for the middle Upper Palaeolithic site of Předmosti (Moravia, Czech Republic): Pleistocene wolf and Palaeolithic dog (Germonpre et al., 2012, 2015; Galeta et al., 2020). In Wilczynski et… read more here.
Keywords: friend foe; comments friend; foe large; canid remains ... See more keywords